Gambro equipment connected to patient deaths in Hong Kong following similar incident in the US
This article was originally published in Clinica
Investigations are underway into the deaths of three patients in a private hospital in Hong Kong following treatment with Gambro's dialyser equipment. The incident comes three months after the company was forced to recall blood tubing after four patients died in the US. The company has also been hit by problems in its European factories, which have forced it to buy products from competitors.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.